Thursday, December 26, 2024
FGF
FGF
FGF

New information reveals optimum timing for percutaneous coronary intervention in TAVR sufferers

New information reveals optimum timing for percutaneous coronary intervention in TAVR sufferers

New information reveals that percutaneous coronary intervention (PCI) may be safely carried out earlier than, throughout, or after transcatheter aortic valve alternative (TAVR) for sufferers with steady coronary artery illness (CAD). The outcomes from the evaluation had been introduced as we speak on the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Classes.

For these with CAD, PCI and TAVR are sometimes required to revive blood circulate. Many clinicians desire to conduct PCI earlier than TAVR because of the potential issues that might happen throughout the alternative process. Nonetheless, the optimum timing for PCI in sufferers present process TAVR is debatable.

The evaluation included 49,344 sufferers with steady CAD who underwent PCI earlier than (84.7%), after (1.3%), or concurrently (14%) with TAVR utilizing the Sapien 3 (S3) platform balloon expandable bioprosthesis. The evaluation was performed utilizing the TVT Registry and Medicare linkage between 2015 and 2024.

In a propensity-matched evaluation, the composite of all-cause mortality and stroke had been related in three teams at three years of follow-up. The authors famous that because of the small numbers of sufferers present process PCIs after the TAVR, after they in contrast simply the 2 different teams (earlier than and concomitant PCIs), PCI carried out earlier than TAVR had a slight benefit over concomitant PCI with TAVR at three years (P=0.012).

These findings are thrilling as they barely differ from beforehand revealed registry information. We consider this information will instill confidence and supply supporting proof for a lot of physicians and coronary heart groups to make selections concerning the timing of PCI in sufferers present process TAVR.”


Abhijeet Dhoble, MD, MPH, FACC, FSCAI, heart specialist at College of Texas Well being Science Heart at Houston, and lead writer of the research

Session particulars:

  • “Timing of Percutaneous Coronary Intervention in Conjunction with Transcatheter Aortic Valve Substitute with Balloon Expandable Valves in the USA”
  • Friday, Might 3, 2024; 3:14-3:21 PM PT
  • Lengthy Seashore Conference Heart, 104A, First Stage

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles